Our Nurse Practitioner will evaluate whether medication is appropriate for you
Accessed 3/20/2025
Patients should verify their specific weight loss medication and treatment coverage, including prior authorization requirements, with UnitedHealthcare before beginning care
Cosmetic Peptide Comparison: BPC-157 vs TB-500, IGF-1 vs IGF-1 LR3, Semax vs Selank, GHRP-2 vs Ipamorelin Cosmetic Peptide Comparison: BPC-157 vs TB-500, IGF-1 vs IGF-1 LR3, Semax vs Selank, and GHRP-2 vs Ipamorelin At a glance BPC-157 half-life / approximately 4 hours (subcutaneous or intramuscular) TB-500 half-life / longer systemic distribution, dosed 2-4 mg twice weekly IGF-1 LR3 active window / up to 20 hours vs ~20 minutes for native IGF-1 Semax mechanism / upregulates BDNF and dopamine receptor sensitivity Selank mechanism / enhances GABA-A tone and reduces IL-6 by ~30% in animal models GHRP-2 GH pulse / strong but co-elevates cortisol and prolactin Ipamorelin GH pulse / selective
For those navigating the expanding landscape of dual-agonist peptides, SeekPeptides provides comprehensive comparisons, evidence-based protocols, and practical guidance for choosing and using these compounds effectively
In a 68-week study, about 1 in 3 adults with obesity or overweight and weight-related conditions achieved 20% weight loss
